CIK: 0001560009
Total reported value
$141.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 77.19% | -0.16% | -0.67% | |
| 2 | VCYT | Veracyte INC | Stock-Other | 10.14% | — | — | |
| 3 | 2JQ | Gritstone Bio INC | Stock-Other | 8.39% | — | — | |
| 4 | OCUL | Ocular Therapeutix INC | Stock-Other | 2.64% | — | — | |
| 5 | ✓ | Second Sight Med Prods INC | Stock-Other | 1.01% | — | — | |
| 6 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 0.32% | — | — | |
| 7 | CLVSEUR | Clovis Oncology INC | Stock-Other | 0.32% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CRSP | CRISPR Therapeutics AG | +10% | -0.67% | Trim |
| 2 | CLVSEUR | Clovis Oncology INC | +0.2% | — | Unchanged |
| 3 | OCUL | Ocular Therapeutix INC | 0% | — | Unchanged |
| 4 | ✓ | Second Sight Med Prods INC | -0.4% | — | Unchanged |
| 5 | CBAYUSD | Cymabay Therapeutics INC | -0.8% | — | Unchanged |
| 6 | VCYT | Veracyte INC | -1.1% | — | Unchanged |
| 7 | 2JQ | Gritstone Bio INC | -2% | — | Unchanged |
| 8 | BOLDEUR | Audentes Therapeutics INC | — | EXIT | Sold out |